Hedge funds turn to doctors and scientists to gain pharma market edge
Some of the world’s largest hedge funds including Balyasny Asset Management and DE Shaw, are recruiting doctors, scientists, and healthcare analysts to gain specialised insights into pharmaceutical stocks amid heightened volatility in the sector, according to a report by Reuters.

